| Trial Identifier: | D2270C00020 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02599714 |
| Start Date: | December 2015 |
| Primary Completion Date: | March 2018 |
| Study Completion Date: | December 2023 |
| Condition: | Breast Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| English Translation |
| Country | Location |
|---|---|
| GB | Liverpool, GB, L7 8XP |
| GB | London, GB, W1G 6AD |
| US, CA | Encinitas, CA, US, 92024 |
| US, FL | Sarasota, FL, US, 34232 |
| US, MI | Detroit, MI, US, 48201 |
| US, TN | Nashville, TN, US, 37203 |
| US, WI | Milwaukee, WI, US, 53226 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company